Author: OurCrowd

[QuantLR in Startup News] Bezeq to foreshadow Quantum era cyber threats with a HEQA Security strategic partnership

Apr 17, 2024 |

In a first of its kind collaboration, Bezeq and HEQA Security have joined forces to pioneer quantum cybersecurity. This partnership sees Bezeq set to deploy an innovative encryption key distribution network, uniquely positioning it as the first Israeli telecom to fortify its infrastructure against the burgeoning threat of quantum cyber-attacks. These advanced cyber threats pose significant risks to critical sectors including finance, healthcare, and defense, underlining the urgency of preemptive security measures. Read...

Read More

[Scopio in Startup News] Scopio Labs receives groundbreaking FDA clearance for first-ever digital bone marrow aspirate application

Apr 17, 2024 |

Scopio Labs, developer of Full-Field Digital Cell Morphology™ imaging and analysis platforms and a recognized leader in digital morphology, today announced that it has been granted De Novo clearance by the U.S. Food and Drug Administration (FDA) for its Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. This marks a pivotal moment, establishing a new regulatory category for all-digital bone marrow aspirate analysis software. Read more...

Read More

[Surgical Theater in Startup News] Orthoidny announces first spine surgery utilizing Surgical Theater’s XR Technology

Apr 17, 2024 |

OrthoIndy has announced a monumental step forward in surgical innovation by introducing augmented reality (AR) into surgical procedures. Distinguished spine surgeon, Dr. Gregory Poulter, recently performed Indiana’s first-ever surgery utilizing Surgical Theater’s cutting-edge eXperiential Reality (XR) technology. OrthoIndy is one of only five sites in the world where this advanced approach is being used. The procedure, a pioneering spinal fusion, was executed using the Surgical Theater SyncAR® Spine platform, incorporating Microsoft HoloLens headsets for an enhanced visual experienc Read...

Read More

[Colossal in The Science Times] Colossal Biosciences’ New Chief Science Officer Beth Shapiro on the Science Behind De-Extinction

Apr 17, 2024 |

Colossal Biosciences has been making waves since its founding in 2021, thanks to its ambitious and controversial goal of reviving lost species like the woolly mammoth and dodo. While many have compared the company’s efforts to that of the Jurassic Park book and film franchise, Colossal’s work is rooted in the use of next-generation technologies and pioneering conservation tactics that have been studied and debated for years. Read more...

Read More